| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/03/2008 | WO2008077453A1 5-fluorouracil derivatives and their use for the treatment of cancer |
| 07/03/2008 | WO2008077404A1 Substituted acetophenones useful as pde4 inhibitors |
| 07/03/2008 | WO2008077356A1 Pharmaceutical compositions capable of inducing apoptosis in tumour cells, useful for diagnosis and treatment of b-chronic lymphocytic leukaemia |
| 07/03/2008 | WO2008077311A1 Hepatopoietin and use thereof |
| 07/03/2008 | WO2008077276A1 An injectable solution of spider venom and preparation thereof |
| 07/03/2008 | WO2008077247A1 Coatings for implantable medical devices comprising cholesterol |
| 07/03/2008 | WO2008077236A1 Adp-ribosyl transferase fusion variant proteins |
| 07/03/2008 | WO2008057291A3 Crystalline and amorphous imatinib base, imatinib mesylate- and processes for preparation thereof |
| 07/03/2008 | WO2008054594A3 Method for controlling angiogenesis in animals |
| 07/03/2008 | WO2008051493A3 Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors |
| 07/03/2008 | WO2008041088A3 N-hydroxy benzamides with antitumor activity |
| 07/03/2008 | WO2008034796A3 Estratriene derivatives and their uses as 17beta-hydr0xyster0id dehydrogenase inhibitors |
| 07/03/2008 | WO2008027013A3 Combination of mtor antagonist and angiogenesis inhibitor for the treatment of cancer |
| 07/03/2008 | WO2008024980A3 Pyrrole, thiophene, furan, imidazole, oxazole, and thiazole derivatives |
| 07/03/2008 | WO2008023362A3 Use of a combination of methotrexate and an a3ar agonist for the treatment of cancer |
| 07/03/2008 | WO2008002676A9 Biaryl compositions and methods for modulating a kinase cascade |
| 07/03/2008 | WO2007147613A3 Combinations comprising staurosprorines |
| 07/03/2008 | WO2007140299A3 Use of ixabepilone in combination with cyp3a4 inhibitors for pharmaceuticals |
| 07/03/2008 | WO2007139939A3 Methods and compositions using immunomodulatory compounds in combination therapy |
| 07/03/2008 | WO2007119214A3 Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis |
| 07/03/2008 | WO2007113322A3 Substituted 5-hetarylpyrimidines for combating plant pathogenic fungi and cancers |
| 07/03/2008 | US20080161562 2-(6-Chloro-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile |
| 07/03/2008 | US20080161426 p53 Inhibitors and Therapeutic Use of the Same |
| 07/03/2008 | US20080161404 Metastatic prostate cancer |
| 07/03/2008 | US20080161401 Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors |
| 07/03/2008 | US20080161391 Novel curcumin analogues and uses thereof |
| 07/03/2008 | US20080161382 Suspensions of docetaxel particles with protein or polymer stabilizing agent; shorter administration times; reducing toxicity and hypersensitivity side effects |
| 07/03/2008 | US20080161369 Open label, single arm, two stage, multicenter study; patients who have not responded to taxane/platinum therapy or have relapsed within six months |
| 07/03/2008 | US20080161358 Cyanoamide Compounds Useful as Malonyl-COA Decarboxylase Inhibitors |
| 07/03/2008 | US20080161355 Combinations of Pyrazole Kinase Inhibitors and Further Antitumor Agents |
| 07/03/2008 | US20080161351 Peroxisome proliferator-activated receptor (PPAR) delta modulators; inhibitors of inducible nitric oxide synthase (iNOS) or tumor necrosis factor (TNF); metabolic disorders, inflammatory diseases and cancer |
| 07/03/2008 | US20080161349 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 07/03/2008 | US20080161343 Sigma 2 Receptor Ligands and Therapeutic Uses Therefor |
| 07/03/2008 | US20080161334 Macrolides |
| 07/03/2008 | US20080161330 e.g. 5-chloro-2-{4-methoxy-2-[3-(pyrid-2-yl)isoxazol-5-yl]pyrrolidin-1-yl}-4-(5-methyl-1H-pyrazol-3-ylamino)pyrimidine; insulin-like growth factor (somatomedin) antagonist; antiproliferation, anticarcinogenic, antitumor agent |
| 07/03/2008 | US20080161328 5-Substituted quinazolinone derivatives and compositions comprising and methods of using the same |
| 07/03/2008 | US20080161320 Fused bicyclic pyrimidines as ptk inhibitors containing a zinc binding moiety |
| 07/03/2008 | US20080161317 Inhibitors of Akt activity |
| 07/03/2008 | US20080161312 Derivatives of Pyrrolo-Pyrazines Having a Kinase Inhibitory Activity and Their Biological Applications |
| 07/03/2008 | US20080161310 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 07/03/2008 | US20080161293 Antitumor Agent |
| 07/03/2008 | US20080161292 Inhibitors of poly(adp-ribose)polymerase |
| 07/03/2008 | US20080161280 Inhibitors of poly(adp-ribose)polymerase |
| 07/03/2008 | US20080161277 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
| 07/03/2008 | US20080161270 Angiogenesis inhibitors |
| 07/03/2008 | US20080161257 Oligonucleotide-Containing Pharmacological Compositions And Their Use |
| 07/03/2008 | US20080161253 Composition for the treatment of nasopharyngeal carcinoma and method of use thereof |
| 07/03/2008 | US20080161252 (E)-2-(5-((2,4,6-trimethoxystyrylsulfonyl)methyl)-2-methoxyphenylamino)acetic acid; antiproliferative; anticarcinogenic agent : solid tumors, leukemia; "cytoproliferative" diseases: atherosclerosis, fibrosis, Paget's disease; synergistic effect with other active ingredients |
| 07/03/2008 | US20080161251 Combination of a cytotoxic agent such as gemcitabine and a compound that inhibits cyclin dependent kinase (CDK) and/or glycogen synthase kinase (GSK, e.g. GSK-3) such as 4-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide |
| 07/03/2008 | US20080161245 Anthracycline-oligopeptide derivatives which have a protein-binding group such as maleimide and said oligopeptide is cleavable by the prostate-specific antigen (PSA); treating cancer |
| 07/03/2008 | US20080161243 Chimeric B-type natriuretic peptide (BNP) polypeptide for use in treatment and prevention of cardiovascular disorders |
| 07/03/2008 | US20080161240 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 07/03/2008 | US20080161236 Therapeutic nucleic acid-3'-conjugates |
| 07/03/2008 | US20080160576 Anti-alphabeta3 humanized monoclonal antibodies |
| 07/03/2008 | US20080160574 Chimeric coiled coil molecules |
| 07/03/2008 | US20080160103 increased oral bioavailability; cancer, hypercalcemia, osteoporosis, osteopenia, Paget's disease, malignant bone disease, bone degeneration, tissue wounds; inhibition of abnormally increased calcium resorption |
| 07/03/2008 | US20080160095 Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| 07/03/2008 | US20080160090 Laser-Activated Nanothermolysis of Cells |
| 07/03/2008 | US20080160063 particles or coils or stents coated with platelet binding agents are directed to target vasculature, such as the vasculature of solid tumor masses or AV-malformations or aneurysms or endoleaks |
| 07/03/2008 | US20080160041 C-type lectin specific monoclonal antibody conjugate for use in reducing immune response to specific antigens; immunotherapy; immunosuppression; treating allergies and autoimmune diseases |
| 07/03/2008 | US20080160039 Pneumovirus NS proteins antagonize the interferon IFN response |
| 07/03/2008 | US20080160033 Novel Screening Method |
| 07/03/2008 | US20080160031 Method and Composition for Treatment of Neoplasms |
| 07/03/2008 | US20080160029 Treatment with anti-vegf antibodies |
| 07/03/2008 | US20080160028 Phosphodiesterase-4 (PDE-4) inhibitors; for treating bronchial asthma, COPD, rheumatoid arthritis (RA), osteoarthritis, cystic fibrosis, Guillain-Barresyndrome, Crohn's disease, ulcerative colitis, psoriasis, atopic dermatitis, allergic eczemas |
| 07/03/2008 | US20080160026 Apo-2 ligand-anti-her-2 antibody synergism |
| 07/03/2008 | US20080160022 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules |
| 07/03/2008 | US20080160019 Using mixture comprising tyrosine kinase with immunoglobulin-like and EGF-like domains-1 (TIE-1)binding agent and endothelial growth factor antagonist to treat and prevent cell proliferative disorders |
| 07/03/2008 | US20080160013 Using immunoglobulin fusion comprising intergrin binding protein and src homology domains as therapeutic tool in treatment and prevention of cell proliferative and atherosclerotic disorders |
| 07/03/2008 | US20080160012 Using transmembrane protein with EGF-like and 2 follistatin-like domains 2 (TMEFF2) specific immunogllobulin for use in diagnosis, prevention and treatment prostate cancer |
| 07/03/2008 | US20080160005 Interleukin-6 suppressive agent |
| 07/03/2008 | US20080159994 Using threee dimensionally encapsulated progenitor cell mixture as ttherapeutic tool in cartilage repair and reconstructive and cosmetic surgeries |
| 07/03/2008 | US20080159993 Immunotherapeutic methods using epitopes of WT-1 and GATA-1 |
| 07/03/2008 | US20080159986 Modulators of the functions of receptors of the tnf/ngf receptor family and other proteins |
| 07/03/2008 | US20080159981 Methods of therapy for cancers characterized by overexpression of the HER2 receptor protein |
| 07/03/2008 | US20080159980 Glutathione s-transferase (GST); kits |
| 07/03/2008 | US20080159977 Modified, protease resistant, colony stimulating factor for use in treatment and prevention of autoimmune and cell proliferative diseases; directed protein evolution |
| 07/03/2008 | US20080159955 Inhibiting the growth of tumor cells overexpressing MN protein with enzyme inhibitors of carbonic anhydrase (CA 1X) (MN protein); pyridinium derivatives of aromatic heterocyclic sulfonamides; side-effect reduction; antitumor, -carcinogenic, -metastasis agents |
| 07/03/2008 | DE102007054065A1 An Flavonoiden reiches Gewebe aus Neomarica gracilis und Verfahren zum Kultivieren desselben Flavonoid-rich tissue from Neomarica gracilis and method thereof for culturing |
| 07/03/2008 | CA2832111A1 Antibodies and methods for making and using them |
| 07/03/2008 | CA2709428A1 Adp-ribosyl transferase fusion variant proteins |
| 07/03/2008 | CA2684165A1 Oligonucleotide-prolyethylene glycol compound |
| 07/03/2008 | CA2676188A1 Pharmaceutical compositions capable of inducing apoptosis in tumour cells, useful for diagnosis and treatment of the b-chronic lymphocytic leukemia |
| 07/03/2008 | CA2674557A1 2-substituted-6-heterocyclic pyrimidone derivatives |
| 07/03/2008 | CA2674512A1 Amino nicotinic and isonicotinic acid derivatives as dhodh inhibitors |
| 07/03/2008 | CA2673736A1 Compounds and methods for kinase modulation, and indications therefor |
| 07/03/2008 | CA2673725A1 Antibodies and methods for making and using them |
| 07/03/2008 | CA2673647A1 Mapk/erk kinase inhibitors |
| 07/03/2008 | CA2673522A1 Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer |
| 07/03/2008 | CA2673472A1 5-cyan0-4- (pyrrolo) [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 07/03/2008 | CA2673410A1 Pyrrolo [3, 2-a] pyridine derivatives for inhibiting ksp kinesin activity |
| 07/03/2008 | CA2673370A1 Substituted acetophenones useful as pde4 inhibitors |
| 07/03/2008 | CA2673299A1 Pyridazinones compounds for the treatment of proliferative diseases |
| 07/03/2008 | CA2673184A1 New compounds |
| 07/03/2008 | CA2673041A1 4-{4-[({3-tert-butyl-1-[3-(hydroxymethyl) phenyl]-1h-pyrazol-5-yl } carbamoyl)-amino] -3-fluorophenoxy} -n-methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer |
| 07/03/2008 | CA2673038A1 Substituted tricyclic heteroaryl compounds as janus kinase inhibitors |
| 07/03/2008 | CA2673003A1 Quinazolines for pdk1 inhibition |
| 07/03/2008 | CA2673000A1 Pyrrolo [2, 3-b] pyridine derivatives as kinase modulators |
| 07/03/2008 | CA2672951A1 Hydroxy methyl phenyl pyrazolyl urea compound useful in the treatment of cancer |
| 07/03/2008 | CA2672718A1 Pyrimidyl derivatives as protein kinase inhibitors |